JP2008523153A5 - - Google Patents

Download PDF

Info

Publication number
JP2008523153A5
JP2008523153A5 JP2007546852A JP2007546852A JP2008523153A5 JP 2008523153 A5 JP2008523153 A5 JP 2008523153A5 JP 2007546852 A JP2007546852 A JP 2007546852A JP 2007546852 A JP2007546852 A JP 2007546852A JP 2008523153 A5 JP2008523153 A5 JP 2008523153A5
Authority
JP
Japan
Prior art keywords
ginger
green tea
reducing
disease
symptoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007546852A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008523153A (ja
Filing date
Publication date
Priority claimed from US11/012,764 external-priority patent/US7166435B2/en
Application filed filed Critical
Publication of JP2008523153A publication Critical patent/JP2008523153A/ja
Publication of JP2008523153A5 publication Critical patent/JP2008523153A5/ja
Pending legal-status Critical Current

Links

JP2007546852A 2004-12-14 2005-12-14 疾病の伝染を減少させる組成物及び方法 Pending JP2008523153A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/012,764 US7166435B2 (en) 2001-08-06 2004-12-14 Compositions and methods for reducing the transmissivity of illnesses
PCT/US2005/045218 WO2006065889A2 (en) 2004-12-14 2005-12-14 Compositions and methods for reducing the transmissivity of illnesses

Publications (2)

Publication Number Publication Date
JP2008523153A JP2008523153A (ja) 2008-07-03
JP2008523153A5 true JP2008523153A5 (https=) 2009-02-26

Family

ID=36588501

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007546852A Pending JP2008523153A (ja) 2004-12-14 2005-12-14 疾病の伝染を減少させる組成物及び方法

Country Status (12)

Country Link
US (2) US7166435B2 (https=)
EP (1) EP1825007A4 (https=)
JP (1) JP2008523153A (https=)
KR (1) KR20070102487A (https=)
CN (1) CN101111608A (https=)
AU (1) AU2005317104A1 (https=)
CA (1) CA2590340A1 (https=)
IL (1) IL183840A0 (https=)
MX (1) MX2007007075A (https=)
NZ (1) NZ555778A (https=)
WO (1) WO2006065889A2 (https=)
ZA (1) ZA200704718B (https=)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7166435B2 (en) * 2001-08-06 2007-01-23 The Quigley Corporation Compositions and methods for reducing the transmissivity of illnesses
US20100286462A1 (en) * 2002-12-19 2010-11-11 Araba L.L.C. Apparati and Method for Remediating Biologically Active Particles
CA2540085C (en) 2003-09-29 2010-11-16 Bruce Michael Koivisto High alcohol content gel-like and foaming compositions
DE102004062775A1 (de) 2004-12-21 2006-06-29 Stockhausen Gmbh Alkoholischer Pumpschaum
CN103417388A (zh) 2005-03-07 2013-12-04 戴博全球保健有限公司 含有有机硅表面活性剂的高醇含量发泡组合物
US20060204466A1 (en) * 2005-03-08 2006-09-14 Ecolab Inc. Hydroalcoholic antimicrobial composition with skin health benefits
US7507425B2 (en) * 2005-09-27 2009-03-24 The Quigley Corporation Method for the treatment of cachexia
WO2007046966A2 (en) * 2005-10-13 2007-04-26 Milkhaus Laboratory, Inc Methods for the treatment of influenza
US20090186012A1 (en) * 2005-11-16 2009-07-23 Natbio Pty. Ltd. Plant extract
US20070148101A1 (en) * 2005-12-28 2007-06-28 Marcia Snyder Foamable alcoholic composition
GB0602325D0 (en) * 2006-02-06 2006-03-15 Remedy Res Ltd Virucidal compositions and uses
MX2009006396A (es) * 2006-12-14 2009-06-26 The Quigley Corp Composiciones y metodos para tratar bronquitis infecciosa.
EP2091548A1 (en) * 2006-12-14 2009-08-26 The Quigley Corporation Methods for treating and reducing the incidence of newcastle disease
KR101481040B1 (ko) * 2008-03-31 2015-01-14 한국화학연구원 [10]-진저다이온 또는 1-데하이드로-[10]-진저다이온을 포함하는 항 염증용 조성물
US20090324734A1 (en) * 2008-06-26 2009-12-31 Daniel Dickey Throat care composition
US7842725B2 (en) 2008-07-24 2010-11-30 Ecolab USA, Inc. Foaming alcohol compositions with selected dimethicone surfactants
US9540322B2 (en) 2008-08-18 2017-01-10 Yale University MIF modulators
FR2937538B1 (fr) * 2008-10-23 2010-12-31 Muselier Corinne Treger Produit antigrippal
WO2010062835A1 (en) * 2008-11-26 2010-06-03 Perio Sciences, Llc Antioxidant compositions for soft oral tissue and methods of formulation and use there
WO2010062260A1 (en) * 2008-11-29 2010-06-03 The Thailand Research Fund Virus and target cell interaction inhibition
US20100151056A1 (en) * 2008-12-16 2010-06-17 Hanan Polansky Dietary supplements for decreasing the latent foreign dna load
US20100178364A1 (en) * 2009-01-12 2010-07-15 Hanan Polansky Dietary supplements against latent foreign DNA
US8906414B1 (en) 2009-04-27 2014-12-09 University Of South Florida Methods and compositions for improving bioavailability of epigallocatechin gallate (EGCG)
KR101186264B1 (ko) * 2009-06-12 2012-09-27 한국생명공학연구원 산자나무 추출물 또는 이로부터 분리된 화합물을 포함하는 ｉｌ-6으로 매개되는 질환 또는 라이노바이러스 감염성 질환의 예방 또는 치료용 조성물
WO2011005043A2 (ko) * 2009-07-08 2011-01-13 한국생명공학연구원 울금 추출물을 포함하는 인플루엔자 바이러스 감염의 예방 및 치료용 조성물 및 뉴라미니데이즈 활성의 억제용 조성물
KR101077920B1 (ko) 2009-07-08 2011-10-31 한국생명공학연구원 울금 추출물을 포함하는 인플루엔자 바이러스 감염의 예방 및 치료용 조성물 및 뉴라미니데이즈 활성의 억제용 조성물
US20110052727A1 (en) * 2009-08-31 2011-03-03 Hanan Polansky Anti Influenza Nutritional Supplements
KR101032066B1 (ko) * 2009-10-08 2011-05-02 한국생명공학연구원 호장근 추출물, 이의 분획물 또는 스틸벤계 화합물을 포함하는 감기의 예방 및 치료용 약학 조성물
ES2553766T3 (es) 2009-10-22 2015-12-11 Maresins Pharma, Inc. Composiciones herbicidas que comprenden jengibre y solidago para el tratamiento de infección por gripe
CN107050401A (zh) * 2009-12-29 2017-08-18 希尔氏宠物营养品公司 用于改善或预防炎性病况的包含姜的组合物
KR101282990B1 (ko) * 2011-05-30 2013-07-04 건국대학교 산학협력단 항 인플루엔자 활성을 갖는 녹차 및 녹차부산물의 지용성 분획과 이로부터 분리된 글리세롤 당지질 화합물
CA2849910A1 (en) 2011-09-30 2013-04-04 Perio Sciences, Llc Antioxidant compositions for treatment of inflammation or oxidative damage
AU2014233363B2 (en) * 2013-03-15 2017-06-29 EyePoint, Inc. Compositions, formulations and methods for treating ocular diseases
US9439841B2 (en) 2013-06-06 2016-09-13 Ecolab Usa Inc. Alcohol based sanitizer with improved dermal compatibility and feel
NL1040474C2 (en) * 2013-10-31 2015-05-04 Veramed B V Nasal compositions stimulating ciliary activity.
WO2015081319A2 (en) * 2013-11-27 2015-06-04 Research Foundation Of The City University Of New York Activity enhancing curcumin compositions and methods of use
CN104013888A (zh) * 2014-07-01 2014-09-03 刘德学 治疗痰热郁肺型阻塞性肺气肿的中药组合物及其制备方法
US10537548B2 (en) 2014-08-28 2020-01-21 Caliway Biopharmaceuticals Co., Ltd. Composition and medical product for reducing body weight and body fat, and use of said product
CN106794215A (zh) 2014-08-28 2017-05-31 康霈生技股份有限公司 用于减少体重及减少体脂肪的组合物及其医药品与应用
KR101687337B1 (ko) * 2015-06-02 2016-12-16 (주)이엘티사이언스 가축 방역용 발판 소독약품 복합조성물 및 그 제조방법
EP3103465A1 (en) * 2015-06-10 2016-12-14 Raman Mehta Formulations for the treatment of mucosal lesions
CN105012831A (zh) * 2015-08-05 2015-11-04 李强 一种用于治疗月经不调的中药组合物
US12447166B2 (en) 2016-02-25 2025-10-21 Applied Biological Laboratories, Inc. Compositions and methods for protecting against airborne pathogens and irritants
MX2018010198A (es) 2016-02-25 2019-06-12 Applied Biological Laboratories Inc Composiciones y metodos para proteger contra patogenos e irritantes transportados por el aire.
ITUA20161822A1 (it) * 2016-03-18 2017-09-18 Indena Spa Composizioni utili nella prevenzione e/o nel trattamento di patologie del cavo orale, delle prime vie aeree e dell’esofago
JP7441042B2 (ja) * 2016-12-02 2024-02-29 シムライズ アーゲー 化粧品ブレンド
WO2019139863A1 (en) * 2018-01-09 2019-07-18 E2Bio Life Sciences, Llc Method and device for the enhancement of topical treatments for oral mucositis and other oral conditions
EP3714889A1 (en) * 2019-03-29 2020-09-30 F. Hoffmann-La Roche AG Baloxavir for the prevention of transmission of influenza virus
KR102224051B1 (ko) * 2019-04-04 2021-03-09 한국 한의학 연구원 건강 추출물을 유효성분으로 포함하는 중화항체 생성율 증진용 조성물
WO2021080388A1 (ko) * 2019-10-25 2021-04-29 한국생명공학연구원 커큐미노이드계 화합물, 및 감초 추출물 또는 이의 분획물을 포함하는 복합체를 포함하는 돼지 유행성 설사 바이러스 감염의 예방 또는 치료용 조성물
CN111402968B (zh) * 2020-04-01 2023-11-03 上海交通大学 基于分子模拟发现山柰酚在covid-19病毒中的新用途
KR102456749B1 (ko) 2020-04-28 2022-10-21 서울대학교산학협력단 울금 (Curcuma longa) 추출물 또는 이로부터 분리한 세스퀴테르페노이드계 화합물을 유효성분으로 포함하는 돼지 인플루엔자 바이러스 감염의 예방 또는 치료용 조성물
US20210393679A1 (en) 2020-06-18 2021-12-23 MELISA INSTITUTE, GENOMICS & PROTEOMICS RESEARCH SpA FORMULATION, USE AND METHOD FOR BROAD-SPECTRUM PROPHYLAXIS AND TREATMENT OF VIRAL INFECTIONS CAUSED BY SARS-CoV-2 AND OTHER EMERGING VIRUSES
CA3185062A1 (en) 2020-07-06 2022-01-13 Gang Pu Foaming mixed alcohol/water compositions comprising a structured alkoxylated siloxane
EP4176031A1 (en) 2020-07-06 2023-05-10 Ecolab USA Inc. Peg-modified castor oil based compositions for microemulsifying and removing multiple oily soils
CN116075583A (zh) 2020-07-06 2023-05-05 埃科莱布美国股份有限公司 包含烷基硅氧烷和水溶助剂/增溶剂的组合的发泡混合醇/水组合物
WO2022036316A1 (en) * 2020-08-14 2022-02-17 North Carolina State University Methods to use flavonoids for inhibition of sars-cov-2 and treatment of covid-19
WO2022046668A1 (en) * 2020-08-22 2022-03-03 Luc Montagnier Compositions and methods for reducing the transmissivity of illnesses
CN113975223A (zh) * 2021-08-06 2022-01-28 华中科技大学 一种鼻腔清洗液

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2850151B2 (ja) 1990-02-02 1999-01-27 日研フード本社株式会社 抗酸化ミネラル飲料及びその製造法
US5120538A (en) 1990-02-05 1992-06-09 Pt Darya-Varia Laboratoria Combinations of compounds isolated from curcuma spp as anti-inflammatory agents
SE468893B (sv) 1991-09-04 1993-04-05 Tetra Alfa Holdings Oeppningsanordning foer foerpackningsbehaallare
CN1060012A (zh) 1991-09-20 1992-04-08 沈阳市铁西区科发医药饮料技术服务部 一种口香糖的制作方法
US5248504A (en) 1992-03-02 1993-09-28 Friedman William H Method of treatment for nasal and sinus dysfunction
CN1072823A (zh) 1992-06-13 1993-06-09 文士开 果酶茶的配制方法
US6063381A (en) 1993-05-19 2000-05-16 Staggs; Jeff J. Therapeutic uses of pungent botanicals and their related compounds
US5401504B1 (en) 1993-12-28 1998-04-21 Univ Mississippi Medical Cente Use of tumeric in wound healing
CN1116068A (zh) 1994-01-25 1996-02-07 刘俊松 天然乳化果茶主剂的制备方法
US5908857A (en) 1994-03-18 1999-06-01 Fujio Suzuki Agent for the treatment of infections
US5494668A (en) 1994-07-11 1996-02-27 Patwardhan; Bhushan Method of treating musculoskeletal disease and a novel composition therefor
US5707630A (en) 1996-01-04 1998-01-13 Sabina International, Ltd. Herbal compound for relief of PMS through menopausal symptoms
US5861415A (en) 1996-07-12 1999-01-19 Sami Chemicals & Extracts, Ltd. Bioprotectant composition, method of use and extraction process of curcuminoids
JPH11155538A (ja) * 1997-11-27 1999-06-15 Uenoya Bikouen:Kk 生姜湯の製造方法
JP2000157209A (ja) 1998-11-27 2000-06-13 Kagetoshi Kawauchi 振り掛け健康食品
US6174542B1 (en) 1999-07-01 2001-01-16 Pms Mood Food, Inc. Dietary supplements and food products for treating symptoms of PMS
US6264995B1 (en) 1999-10-19 2001-07-24 Thomas Newmark Herbal composition for reducing inflammation and methods of using same
US6261607B1 (en) 1999-10-19 2001-07-17 Thomas Newmark Composition for promoting prostate health containing selenium and herbal extracts
US6291533B1 (en) 1999-12-22 2001-09-18 Vitamerica, Inc. Dietary supplements for each specific blood type
US6841544B2 (en) 2000-02-23 2005-01-11 Bioselect Innovations, Inc. Composition and method for treating the effects of diseases and maladies
US6274177B1 (en) 2000-08-26 2001-08-14 National Science Council Method of preparing an extract potent in anti-inflammation and anti-platelet aggregation from Zingiber officinale and pharmaceutical compositions containing said extract
US6391346B1 (en) 2001-04-05 2002-05-21 Thomas Newmark Anti-inflammatory, sleep-promoting herbal composition and method of use
US6592896B2 (en) 2001-08-06 2003-07-15 The Quigley Corporation Medicinal composition and method of using it
US6596313B2 (en) 2001-08-06 2003-07-22 The Quigley Corporation Nutritional supplement and methods of using it
US7166435B2 (en) * 2001-08-06 2007-01-23 The Quigley Corporation Compositions and methods for reducing the transmissivity of illnesses
US7396546B2 (en) * 2001-08-06 2008-07-08 The Quigley Corporation Anti-microbial compositions and methods of using same
NZ537821A (en) * 2002-08-06 2007-05-31 The Quigley Corp Anti-viral compositions useful for treating one or more adverse effects of viral infections

Similar Documents

Publication Publication Date Title
JP2008523153A5 (https=)
RU2350327C2 (ru) Составы, вызывающие потерю веса
Qu et al. Rutin attenuates vancomycin-induced nephrotoxicity by ameliorating oxidative stress, apoptosis, and inflammation in rats
RU2470016C2 (ru) Производное бипиразола
BRPI1013394A2 (pt) "composto, composição farmacêutica, uso do composto, e, método para tratar um paciente infectado com virus da hepatite c."
JP2007302683A5 (https=)
MY169275A (en) Method of immunization against the four serotypes of dengue
EP2305698A3 (en) Macrocyclic inhibitors of Hepatitis C virus replication
JP2012530723A5 (https=)
CL2007001917A1 (es) Compuestos derivados de azaindol espirociclicos; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento del dolor, condiciones de panico, depresion, mal de alzheimer, migrana, entre otras.
JP2010540547A5 (https=)
JP2013537891A5 (https=)
CL2009001899A1 (es) Composicion farmaceutica que comprende: i) un antagonista del receptor de at1 o una sal, ii) un sensibilizante a la insulina o una sal y iii) un vehiculo farmaceuticamente aceptable; uso para la prevencion, demora de progreso o tratamiento de hipertension, diabetes, entre otras (div. sol. 2034-01).
JP2011527299A5 (https=)
FR2878161B1 (fr) Forme medicamenteuse orale, solide et concue pour eviter le mesusage
ATE499939T1 (de) Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend
MA33463B1 (fr) Compositions à dose pharmaceutique solide fixe comprenant de l'irbésartan et de l'amlodipine, leur préparation et leur application thérapeutique
AR063497A1 (es) Compuesto de pirrodinil -2-ona, intermediario para la sintesis del mismo, composicion farmaceutica que lo comprende y su uso para preparar un medicamento
AR065342A1 (es) Composiciones farmaceuticas que contienen fumarato de quetiapina
RU2017127509A (ru) Композиции и способы для улучшенного мышечного метаболизма
JP2006511538A5 (https=)
JP2009515987A5 (https=)
WO2007048027A3 (en) Combination of a renin-inhibitor and an anti-dyslipidemic agent and/or an antiobesity agent
WO2006138373A3 (en) MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF
JP2020536098A5 (https=)